Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4510281

O=C(Nc1cnn(Cc2ccc(F)cc2)c1)N1CCOC(COc2cc(F)ccc2F)C1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 3/20 0.44
RAB9A P51151 2/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
NAMPT P43490 1/20 0.43
KDM4E B2RXH2 3/20 0.43
HSD17B10 Q99714 3/20 0.43
MAPK1 P28482 2/20 0.43
USP2 O75604 1/20 0.43
TSHR P16473 1/20 0.43
DRD4 P21917 1/20 0.42
TCF4 P15884 1/20 0.42
CTNNB1 P35222 1/20 0.42
ALDH1A1 P00352 3/20 0.41
HTT P42858 1/20 0.41
CCR3 P51677 3/20 0.41
EPHA2 P29317 1/20 0.41
KDR P35968 1/20 0.41
EPHB4 P54760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4504696 0.94 TCF4 (0.46) SMN1; SMN2LMNARAB9AMAPTNPC1
Trifluoroacetic Acid SCHEMBL4499863 0.93 SMN1; SMN2 (0.44) SMN1; SMN2LMNARAB9AMAPTNPC1
Trifluoroacetic Acid SCHEMBL4514820 0.91 DRD4 (0.43) SMN1; SMN2LMNARAB9AMAPTNPC1
Trifluoroacetic Acid SCHEMBL4503307 0.90 SMN1; SMN2 (0.44) SMN1; SMN2LMNARAB9AMAPTNPC1
Trifluoroacetic Acid SCHEMBL4505611 0.90 DRD4 (0.44) SMN1; SMN2LMNARAB9AMAPTNPC1
Trifluoroacetic Acid SCHEMBL4507519 0.90 TCF4 (0.44) SMN1; SMN2LMNARAB9AMAPTNPC1
Trifluoroacetic Acid SCHEMBL4507090 0.90 DRD4 (0.46) SMN1; SMN2LMNARAB9AMAPTNPC1
Trifluoroacetic Acid SCHEMBL4503487 0.90 TCF4 (0.44) SMN1; SMN2LMNARAB9AMAPTNPC1
Trifluoroacetic Acid SCHEMBL4502154 0.90 TCF4 (0.44) SMN1; SMN2LMNARAB9AMAPTNPC1
Trifluoroacetic Acid SCHEMBL4512342 0.90 DRD4 (0.51) SMN1; SMN2LMNARAB9AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS SMN1; SMN2 2075/4885LMNA 247/4885RAB9A 3368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.